Cancer Research The Future of Cancer Research: Science and Patient Impact  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laurie, N. A.
Right arrow Articles by Hixson, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laurie, N. A.
Right arrow Articles by Hixson, D. C.
[Cancer Research 65, 11010-11017, December 1, 2005]
© 2005 American Association for Cancer Research


Cell and Tumor Biology

Carcinoembryonic Antigen–Related Cell Adhesion Molecule 1a-4L Suppression of Rat Hepatocellular Carcinomas

Nikia A. Laurie, Meghan M. Comegys, Marie P. Carreiro, Jeanne F. Brown, Donna L. Flanagan, Kate E. Brilliant and Douglas C. Hixson

Division of Hematology and Oncology, Department of Medicine, Rhode Island Hospital/Brown University Medical School, Providence, Rhode Island

Requests for reprints: Douglas C. Hixson, Department of Medicine, Rhode Island Hospital/Brown University Medical School, 593 Eddy Street, Providence, RI 02903. Phone: 401-444-8058; Fax: 401-444-8141; E-mail: dhixson{at}lifespan.org.

Carcinoembryonic antigen (CEA)–related cell adhesion molecule 1 (CEACAM1) is a member of the CEA family of immunoglobulin-like adhesion molecules with two major splice variants, CEACAM1a-4L and CEACAM1b-4S, differing in the length of their COOH-terminal cytoplasmic tail. Both forms are down-regulated in prostate and liver carcinomas relative to normal tissues. We have previously shown in a nude mouse xenograft model that restoration of CEACAM1a-4L expression in human prostate carcinoma cells (PC-3) suppresses tumorigenicity, an effect observed with carcinomas from several other tissues but never established for hepatocellular carcinomas. In this report, we have examined the effect of CEACAM1a-4L on tumorigenicity of 1682A, a rat hepatocellular carcinoma that grows on the omentum when injected into the peritoneal cavity. Results show that restoration of CEACAM1a-4L expression at levels 13- and 0.45-fold compared with negative controls or normal hepatocytes, respectively, completely suppressed the formation of 1682A tumor nodules on the omentum at 3 weeks after injection. In contrast, 1682A cells infected with CEACAM1b-4S or an empty retroviral vector formed multiple clusters of tumor nodules. Although tumor nodules of 1682A cells positive and negative for CEACAM1a-4L did not display significant differences in histologic organization, aggregates formed in vitro by 1682A-L were smaller in size and displayed enlarged intercellular spaces relative to their 1682A-V counterparts. Restoration of CEACAM1a-4L expression did not elevate levels of apoptosis but seemed to cause an increase in the length of G1. This is the first demonstration of CEACAM1a-4L–induced tumor suppression in liver carcinomas using a quantifiable i.p. syngeneic transplantation model.




This article has been cited by other articles:


Home page
DevelopmentHome page
R. Simper-Ronan, K. Brilliant, D. Flanagan, M. Carreiro, H. Callanan, E. Sabo, and D. C. Hixson
Cholangiocyte marker-positive and -negative fetal liver cells differ significantly in their ability to regenerate the livers of adult rats exposed to retrorsine
Development, November 1, 2006; 133(21): 4269 - 4279.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.